Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Recent advances in research on SMANCS]

H Maeda1

  • 1Dept. of Microbiology, Kumamoto University School of Medicine.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 26, 1998
PubMed
Summary

SMANCS, a polymeric drug for liver cancer, demonstrates high efficacy through the enhanced permeability and retention (EPR) effect. It targets tumors, minimizes side effects, and induces cell damage via superoxide radicals and peroxynitrite formation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydroxyl radical production by H2O2 plus Cu,Zn-superoxide dismutase reflects the activity of free copper released from the oxidatively damaged enzyme.

The Journal of biological chemistry·1992
Same author

Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture.

Journal of cardiovascular pharmacology·1992
Same author

Inhibition of mite protease (Df-protease) with protease inhibitors.

Biochemistry international·1992
Same author

[Pharmacokinetic and clinical studies of cefprozil fine granules in children].

The Japanese journal of antibiotics·1992
Same author

[A case of primary alveolar hypoventilation syndrome with a good response to nocturnal low-flow oxygen inhalation and negative pressure ventilation].

Nihon Kyobu Shikkan Gakkai zasshi·1992
Same author

Microvasculature of normal and hydropic labyrinth.

Scanning microscopy·1992

Area of Science:

  • Polymer chemistry and drug delivery systems.
  • Oncology and cancer therapeutics.
  • Pharmacology and molecular mechanisms of action.

Context:

  • SMANCS is the first polymeric drug approved in Japan (1994) for primary liver cancer.
  • Intra-arterial injection of SMANCS in Lipiodol is a standard treatment.
  • The enhanced permeability and retention (EPR) effect facilitates tumor-selective drug accumulation.

Purpose:

  • To review advances in SMANCS research over the past five years.
  • To discuss the mechanism of tumor-selective accumulation of polymeric drugs.
  • To elucidate the cellular and tissue-level mechanisms of SMANCS action.

Summary:

  • SMANCS exhibits extraordinary cancer targeting efficiency with minimal systemic side effects and prolonged release.
  • Cellular mechanisms involve superoxide radical generation, DNA damage, and immunological potentiation.
  • In vivo, SMANCS induces tissue damage and vascular collapse in tumors through peroxynitrite formation.

Impact:

  • SMANCS treatment shows a dose-dependent relationship with tumor regression.
  • Understanding SMANCS action informs the development of novel polymeric drug delivery systems.
  • Optimizing SMANCS/Lipiodol administration can improve therapeutic outcomes for liver cancer.

Related Experiment Videos